The opening of Merck’s healthcare research and development centre in Bengaluru was announced on Thursday.
The Merck India R&D Excellence Centre helps treat patients with unmet medical needs all around the world by contributing to the company’s healthcare R&D.
About 300 employees are employed in the German pharmaceutical company’s centre, which will keep growing over the next two years.
“Through the Centre, we will increase our involvement in healthcare research and development in India while assisting the Merck Group’s international drug discovery activities. According to Suneela Thatte, vice president and director of the R&D Excellence Centre, the Bangalore centre’s goals are to create a culture of working as a single team, deliver important tasks related to medication development, and build a strong talent base. The statement was reported by ET.
Thatte continued, “The R&D Excellence Centre aspires to unite the finest of local talent and international best practices to enable the vision of increased patient outcomes.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.